{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T21:28:43Z","timestamp":1792877323502,"version":"4.5.0"},"reference-count":45,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2023,7,14]],"date-time":"2023-07-14T00:00:00Z","timestamp":1689292800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,11,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Invasive aspergillosis (IA) in immunocompromised hosts carries high morbidity and mortality. Diagnosis is often delayed because definitive diagnosis requires invasive specimen collection, while noninvasive testing with galactomannan is moderately accurate. Plasma cell-free DNA polymerase chain reaction (cfDNA PCR) represents a novel testing modality for the noninvasive diagnosis of invasive fungal disease (IFD). We directly compared the performance of Aspergillus plasma cfDNA PCR with serum galactomannan for the diagnosis of IA during routine clinical practice.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We conducted a retrospective study of all patients with suspected IFD who had Aspergillus plasma cfDNA PCR testing at Stanford Health Care from 1 September 2020 to 30 October 2022. Patients were categorized into proven, probable, possible, and no IA based on the EORTC\/MSG definitions. Primary outcomes included the clinical sensitivity and specificity for Aspergillus plasma cfDNA PCR and galactomannan.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Overall, 238 unique patients with Aspergillus plasma cfDNA PCR test results, including 63 positives and 175 nonconsecutive negatives, were included in this study. The majority were immunosuppressed (89.9%) with 22.3% 30-day all-cause mortality. The overall sensitivity and specificity of Aspergillus plasma cfDNA PCR were 86.0% (37 of 43; 95% confidence interval [CI], 72.7\u201395.7) and 93.1% (121 of 130; 95% CI, 87.4\u201396.3), respectively. The sensitivity and specificity of serum galactomannan in hematologic malignancies\/stem cell transplants were 67.9% (19 of 28; 95% CI, 49.3\u201382.1) and 89.8% (53 of 59; 95% CI, 79.5\u201395.3), respectively. The sensitivity of cfDNA PCR was 93.0% (40 of 43; 95% CI, 80.9\u201398.5) in patients with a new diagnosis of IA.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Aspergillus plasma cfDNA PCR represents a more sensitive alternative to serum galactomannan for noninvasive diagnosis of IA.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/cid\/ciad420","type":"journal-article","created":{"date-parts":[[2023,7,14]],"date-time":"2023-07-14T18:07:18Z","timestamp":1689358038000},"page":"1282-1290","source":"Crossref","is-referenced-by-count":40,"title":["Superior Accuracy of <i>Aspergillus<\/i> Plasma Cell-Free DNA Polymerase Chain Reaction Over Serum Galactomannan for the Diagnosis of Invasive Aspergillosis"],"prefix":"10.1093","volume":"77","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7552-4840","authenticated-orcid":false,"given":"Jordan","family":"Mah","sequence":"first","affiliation":[{"name":"Division of Pathology, Stanford University School of Medicine , Stanford, California , USA"},{"name":"Clinical Microbiology Laboratory, Stanford Health Care , Stanford, California , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"Nicholas","sequence":"additional","affiliation":[{"name":"Division of Pathology, Stanford University School of Medicine , Stanford, California , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralph","family":"Tayyar","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine , Stanford, California , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angel","family":"Moreno","sequence":"additional","affiliation":[{"name":"Division of Pathology, Stanford University School of Medicine , Stanford, California , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanagavel","family":"Murugesan","sequence":"additional","affiliation":[{"name":"Division of Pathology, Stanford University School of Medicine , Stanford, California , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Indre","family":"Budvytiene","sequence":"additional","affiliation":[{"name":"Clinical Microbiology Laboratory, Stanford Health Care , Stanford, California , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8501-3000","authenticated-orcid":false,"given":"Niaz","family":"Banaei","sequence":"additional","affiliation":[{"name":"Division of Pathology, Stanford University School of Medicine , Stanford, California , USA"},{"name":"Clinical Microbiology Laboratory, Stanford Health Care , Stanford, California , USA"},{"name":"Division of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine , Stanford, California , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,7,14]]},"reference":[{"key":"2023111209205885200_ciad420-B1","doi-asserted-by":"crossref","first-page":"e01487-19","DOI":"10.1128\/JCM.01487-19","article-title":"Updates in laboratory diagnostics for invasive fungal infections","volume":"58","author":"Terrero-Salcedo","year":"2020","journal-title":"J Clin Microbiol"},{"key":"2023111209205885200_ciad420-B2","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1086\/525258","article-title":"Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America","volume":"46","author":"Walsh","year":"2008","journal-title":"Clin Infect Dis"},{"key":"2023111209205885200_ciad420-B3","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/ciw326","article-title":"Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the Infectious Diseases Society of America","volume":"63","author":"Patterson","year":"2016","journal-title":"Clin Infect Dis"},{"key":"2023111209205885200_ciad420-B4","doi-asserted-by":"crossref","first-page":"4358","DOI":"10.1182\/blood-2002-05-1496","article-title":"Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors","volume":"100","author":"Marr","year":"2002","journal-title":"Blood"},{"key":"2023111209205885200_ciad420-B5","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S1473-3099(05)70238-3","article-title":"Laboratory diagnosis of invasive aspergillosis","volume":"5","author":"Hope","year":"2005","journal-title":"Lancet Infect Dis"},{"key":"2023111209205885200_ciad420-B6","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1093\/cid\/ciz1008","article-title":"Revision and update of the consensus definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium","volume":"71","author":"Donnelly","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2023111209205885200_ciad420-B7","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1086\/503427","article-title":"Diagnosis of invasive aspergillosis using a galactomannan assay: a meta-analysis","volume":"42","author":"Pfeiffer","year":"2006","journal-title":"Clin Infect Dis"},{"key":"2023111209205885200_ciad420-B8","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1128\/JCM.01767-09","article-title":"Aspergillus PCR: one step closer to standardization","volume":"48","author":"White","year":"2010","journal-title":"J Clin Microbiol"},{"key":"2023111209205885200_ciad420-B9","first-page":"CD009551","article-title":"Polymerase chain reaction blood tests for the diagnosis of invasive aspergillosis in immunocompromised people","volume":"9","author":"Cruciani","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"2023111209205885200_ciad420-B10","doi-asserted-by":"crossref","first-page":"3731","DOI":"10.1128\/JCM.01365-14","article-title":"PCR in diagnosis of invasive aspergillosis: a meta-analysis of diagnostic performance","volume":"52","author":"Arvanitis","year":"2014","journal-title":"J Clin Microbiol"},{"key":"2023111209205885200_ciad420-B11","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1086\/499818","article-title":"Polymerase chain reaction for diagnosing invasive aspergillosis: getting closer but still a ways to go","volume":"42","author":"Donnelly","year":"2006","journal-title":"Clin Infect Dis"},{"key":"2023111209205885200_ciad420-B12","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S1473-3099(09)70019-2","article-title":"Use of PCR for diagnosis of invasive aspergillosis: systematic review and meta-analysis","volume":"9","author":"Mengoli","year":"2009","journal-title":"Lancet Infect Dis"},{"key":"2023111209205885200_ciad420-B13","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1093\/cid\/civ507","article-title":"Aspergillus polymerase chain reaction: systematic review of evidence for clinical use in comparison with antigen testing","volume":"61","author":"White","year":"2015","journal-title":"Clin Infect Dis"},{"key":"2023111209205885200_ciad420-B14","doi-asserted-by":"crossref","first-page":"S89","DOI":"10.1093\/cid\/ciaa1786","article-title":"Defining galactomannan positivity in the updated EORTC\/MSGERC consensus definitions of invasive fungal diseases","volume":"72","author":"Mercier","year":"2021","journal-title":"Clin Infect Dis"},{"key":"2023111209205885200_ciad420-B15","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1128\/JCM.02814-15","article-title":"Comparison of performance characteristics of Aspergillus PCR in testing a range of blood-based samples in accordance with international methodological recommendations","volume":"54","author":"Springer","year":"2016","journal-title":"J Clin Microbiol"},{"key":"2023111209205885200_ciad420-B16","doi-asserted-by":"crossref","first-page":"2838","DOI":"10.1128\/JCM.00906-15","article-title":"Analytical comparison of in vitro-spiked human serum and plasma for PCR-based detection of Aspergillus fumigatus DNA: a study by the European Aspergillus PCR Initiative","volume":"53","author":"Loeffler","year":"2015","journal-title":"J Clin Microbiol"},{"key":"2023111209205885200_ciad420-B17","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.1128\/JCM.00905-15","article-title":"Clinical performance of Aspergillus PCR for testing serum and plasma: a study by the European Aspergillus PCR Initiative","volume":"53","author":"White","year":"2015","journal-title":"J Clin Microbiol"},{"key":"2023111209205885200_ciad420-B18","doi-asserted-by":"crossref","first-page":"S60","DOI":"10.1093\/mmy\/myx091","article-title":"Diagnosis of aspergillosis by PCR: clinical considerations and technical tips","volume":"56","author":"Barnes","year":"2018","journal-title":"Med Mycol"},{"key":"2023111209205885200_ciad420-B19","doi-asserted-by":"crossref","first-page":"e00782-19","DOI":"10.1128\/JCM.00782-19","article-title":"Investigation of preanalytical variables impacting pathogen cell-free DNA in blood and urine","volume":"57","author":"Murugesan","year":"2019","journal-title":"J Clin Microbiol"},{"key":"2023111209205885200_ciad420-B20","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1093\/cid\/ciab158","article-title":"Clinical accuracy and impact of plasma cell-free DNA fungal polymerase chain reaction panel for noninvasive diagnosis of fungal infection","volume":"73","author":"Senchyna","year":"2021","journal-title":"Clin Infect Dis"},{"key":"2023111209205885200_ciad420-B21","volume-title":"MedCalc Statistical Software version 19.2.6","year":"2020"},{"key":"2023111209205885200_ciad420-B22","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3390\/jof3040057","article-title":"Global and multi-national prevalence of fungal diseases-estimate precision","volume":"3","author":"Bongomin","year":"2017","journal-title":"J Fungi (Basel)"},{"key":"2023111209205885200_ciad420-B23","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1093\/cid\/ciab1066","article-title":"Evaluation of serum Mucorales polymerase chain reaction (PCR) for the diagnosis of mucormycoses: the MODIMUCOR prospective trial","volume":"75","author":"Millon","year":"2022","journal-title":"Clin Infect Dis"},{"key":"2023111209205885200_ciad420-B24","doi-asserted-by":"crossref","first-page":"e0010122","DOI":"10.1128\/jcm.00101-22","article-title":"Accuracy of Pneumocystis jirovecii plasma cell-free DNA PCR for noninvasive diagnosis of Pneumocystis pneumonia","volume":"60","author":"Moreno","year":"2022","journal-title":"J Clin Microbiol"},{"key":"2023111209205885200_ciad420-B25","doi-asserted-by":"crossref","first-page":"e01061-18","DOI":"10.1128\/JCM.01061-18","article-title":"Does size matter? Comparison of extraction yields for different-sized DNA fragments by seven different routine and four new circulating cell-free extraction methods","volume":"56","author":"Cook","year":"2018","journal-title":"J Clin Microbiol"},{"key":"2023111209205885200_ciad420-B26","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1128\/JCM.00523-12","article-title":"A novel extraction method combining plasma with a whole-blood fraction shows excellent sensitivity and reproducibility for patients at high risk for invasive aspergillosis","volume":"50","author":"Springer","year":"2012","journal-title":"J Clin Microbiol"},{"key":"2023111209205885200_ciad420-B27","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/j.1600-0609.2010.01452.x","article-title":"Aspergillus PCR testing: results from a prospective PCR study within the AmBiLoad trial","volume":"85","author":"Hummel","year":"2010","journal-title":"Eur J Haematol"},{"key":"2023111209205885200_ciad420-B28","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1128\/JCM.03322-12","article-title":"Multicenter comparison of serum and whole-blood specimens for detection of Aspergillus DNA in high-risk hematological patients","volume":"51","author":"Springer","year":"2013","journal-title":"J Clin Microbiol"},{"key":"2023111209205885200_ciad420-B29","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.jcrc.2018.07.001","article-title":"Detection of invasive pulmonary aspergillosis in critically ill patients by combined use of conventional culture, galactomannan, 1\u20133-beta-D-glucan and Aspergillus specific nested polymerase chain reaction in a prospective pilot study","volume":"47","author":"Boch","year":"2018","journal-title":"J Crit Care"},{"key":"2023111209205885200_ciad420-B30","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3390\/jof6010018","article-title":"Blood Aspergillus PCR: the good, the bad, and the ugly","volume":"6","author":"Egger","year":"2020","journal-title":"J Fungi"},{"key":"2023111209205885200_ciad420-B31","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1038\/bmt.2010.38","article-title":"Randomized PCR-based therapy and risk factors for invasive fungal infection following reduced-intensity conditioning and hematopoietic SCT","volume":"45","author":"Blennow","year":"2010","journal-title":"Bone Marrow Transplant"},{"key":"2023111209205885200_ciad420-B32","doi-asserted-by":"crossref","first-page":"562.e1","DOI":"10.1016\/j.cmi.2016.01.027","article-title":"Aspergillus PCR in serum for the diagnosis, follow-up and prognosis of invasive aspergillosis in neutropenic and nonneutropenic patients","volume":"22","author":"Imbert","year":"2016","journal-title":"Clin Microbiol Infect"},{"key":"2023111209205885200_ciad420-B33","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.cmi.2015.09.009","article-title":"Prospective multicentre PCR-based Aspergillus DNA screening in high-risk patients with and without primary antifungal mould prophylaxis","volume":"22","author":"Springer","year":"2016","journal-title":"Clin Microbiol Infect"},{"key":"2023111209205885200_ciad420-B34","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1080\/14787210.2018.1558054","article-title":"Improving the rates of Aspergillus detection: an update on current diagnostic strategies","volume":"17","author":"Jenks","year":"2019","journal-title":"Expert Rev Anti Infect Ther"},{"key":"2023111209205885200_ciad420-B35","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1093\/jac\/dkaa498","article-title":"The impact of anti-mould prophylaxis on Aspergillus PCR blood testing for the diagnosis of invasive aspergillosis","volume":"76","author":"Cruciani","year":"2021","journal-title":"J Antimicrob Chemother"},{"key":"2023111209205885200_ciad420-B36","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1086\/500466","article-title":"Prospective evaluation of a polymerase chain reaction-ELISA targeted to Aspergillus fumigatus and Aspergillus flavus for the early diagnosis of invasive aspergillosis in patients with hematological malignancies","volume":"193","author":"Florent","year":"2006","journal-title":"J Infect Dis"},{"key":"2023111209205885200_ciad420-B37","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1111\/j.1365-2141.2005.05887.x","article-title":"Role of prospective screening of blood for invasive aspergillosis by polymerase chain reaction in febrile neutropenic recipients of haematopoietic stem cell transplants and patients with acute leukaemia","volume":"132","author":"Halliday","year":"2006","journal-title":"Br J Haematol"},{"key":"2023111209205885200_ciad420-B38","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/sj.bmt.1704768","article-title":"A prospective study of real-time panfungal PCR for the early diagnosis of invasive fungal infection in haemato-oncology patients","volume":"35","author":"Jordanides","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"2023111209205885200_ciad420-B39","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1128\/JCM.42.6.2733-2741.2004","article-title":"Prospective comparison of the diagnostic potential of real-time PCR, double-sandwich enzyme-linked immunosorbent assay for galactomannan, and a (1\u21923)-\u03b2-D-glucan test in weekly screening for invasive aspergillosis in patients with hematological disorders","volume":"42","author":"Kawazu","year":"2004","journal-title":"J Clin Microbiol"},{"key":"2023111209205885200_ciad420-B40","doi-asserted-by":"crossref","first-page":"3772","DOI":"10.1128\/JCM.01086-08","article-title":"Detection of circulating Aspergillus fumigatus DNA by real-time PCR assay of large serum volumes improves early diagnosis of invasive aspergillosis in high-risk adult patients under hematologic surveillance","volume":"46","author":"Suarez","year":"2008","journal-title":"J Clin Microbiol"},{"key":"2023111209205885200_ciad420-B41","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1093\/cid\/ciu833","article-title":"Serum galactomannan versus a combination of galactomannan and polymerase chain reaction-based Aspergillus DNA detection for early therapy of invasive aspergillosis in high-risk hematological patients: a randomized controlled trial","volume":"60","author":"Aguado","year":"2015","journal-title":"Clin Infect Dis"},{"key":"2023111209205885200_ciad420-B42","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1093\/mmy\/myv051","article-title":"Combining Aspergillus mitochondrial and ribosomal QPCR, in addition to galactomannan assay, for early diagnosis of invasive aspergillosis in hematology patients","volume":"53","author":"Bellanger","year":"2015","journal-title":"Med Mycol"},{"key":"2023111209205885200_ciad420-B43","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1111\/bjh.12285","article-title":"Combined real-time PCR and galactomannan surveillance improves diagnosis of invasive aspergillosis in high risk patients with haematological malignancies","volume":"161","author":"Rogers","year":"2013","journal-title":"Br J Haematol"},{"key":"2023111209205885200_ciad420-B44","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1128\/JCM.03189-12","article-title":"Evaluation of real-time PCR, galactomannan enzyme-linked immunosorbent assay (ELISA), and a novel lateral-flow device for diagnosis of invasive aspergillosis","volume":"51","author":"White","year":"2013","journal-title":"J Clin Microbiol"},{"key":"2023111209205885200_ciad420-B45","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1128\/JCM.01682-16","article-title":"Prospective biomarker screening for diagnosis of invasive aspergillosis in high-risk pediatric patients","volume":"55","author":"Loeffler","year":"2017","journal-title":"J Clin Microbiol"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/cid\/advance-article-pdf\/doi\/10.1093\/cid\/ciad420\/51090201\/ciad420.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/77\/9\/1282\/53302526\/ciad420.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/77\/9\/1282\/53302526\/ciad420.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,12]],"date-time":"2023-11-12T09:21:27Z","timestamp":1699780887000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/77\/9\/1282\/7224424"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,14]]},"references-count":45,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2023,7,14]]},"published-print":{"date-parts":[[2023,11,11]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciad420","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,11,1]]},"published":{"date-parts":[[2023,7,14]]}}}